Stay updated on Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s footer software/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:28:31.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:51:09.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:33:41.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Footer revision updated from Revision: v3.4.2 to Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:15:34.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2 and the prior funding/operating-status notice was removed; these are site-wide housekeeping changes rather than updates to study details.
    Difference
    0.4%
    Check dated 2026-02-11T14:30:10.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the system revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:46:36.000Z thumbnail image

Stay in the know with updates to Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.